Pfiz­er opens doors at newest gene ther­a­py site in NC as part of $800M push in­to next-gen drugs

The Covid-19 pan­dem­ic has been an ex­treme­ly prof­itable time for Pfiz­er, and the mas­sive drug­mak­er is us­ing that lever­age to ad­vance its port­fo­lio writ large. Now, Pfiz­er’s emerg­ing gene ther­a­py biz will have some new el­bow room as it con­tin­ues to grow in the com­ing years.

Pfiz­er this week opened a $68.5 mil­lion gene ther­a­py man­u­fac­tur­ing fa­cil­i­ty in Durham, North Car­oli­na, as part of a mul­ti-year, $800 mil­lion plan to out­fit its next-gen ther­a­peu­tics busi­ness, the com­pa­ny said Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER